+Search query
-Structure paper
Title | Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation. |
---|---|
Journal, issue, pages | Signal Transduct Target Ther, Vol. 6, Page 288-288, Year 2021 |
Publish date | May 19, 2020 (structure data deposition date) |
Authors | Xia, S. / Lan, Q. / Zhu, Y. / Wang, C. / Xu, W. / Li, Y. / Wang, L. / Jiao, F. / Zhou, J. / Hua, C. ...Xia, S. / Lan, Q. / Zhu, Y. / Wang, C. / Xu, W. / Li, Y. / Wang, L. / Jiao, F. / Zhou, J. / Hua, C. / Wang, Q. / Cai, X. / Wu, Y. / Gao, J. / Liu, H. / Sun, G. / Munch, J. / Kirchhoff, F. / Yuan, Z. / Xie, Y. / Sun, F. / Jiang, S. / Lu, L. |
External links | Signal Transduct Target Ther / PubMed:34326308 |
Methods | X-ray diffraction |
Resolution | 2.278 Å |
Structure data | PDB-7c53: |
Chemicals | ChemComp-CA: ChemComp-HOH: |
Source |
|
Keywords | VIRAL PROTEIN / SARS-CoV-2 HR1 / pan-CoVs inhibitor / EK1 peptide / VIRUS |